key: cord-0710014-ks9vkgqu
authors: Blanco-Schweizer, Pablo; Sánchez-Ballesteros, Jesús; Herrán-Monge, Rubén; Prieto-deLamo, Ana; de Ayala-Fernández, Jose A; García-García, Marta
title: Interhospital transport of COVID-19 patients on ECMO and comparison with historic controls
date: 2020-10-09
journal: Med Intensiva
DOI: 10.1016/j.medin.2020.09.007
sha: 1185a56ed0cb3977010f92888df0944e467b1491
doc_id: 710014
cord_uid: ks9vkgqu

nan

Extracorporeal membrane oxygenation (ECMO) is a sophisticated therapy that has been associated to reduced mortality in patients with the most severe forms of Acute Respiratory Distress Syndrome (ARDS) (1,2). It is recommended to be performed at high volume centers, in order to have the best possible results (3).

With the aim of equally distributing healthcare resources, specialised "ECMO-Centers" should offer this therapy to patients admitted to other hospitals where ECMO cannot be done safely.

Early reports from China showed that ECMO use during the COVID-19 outbreak was anecdotal (4), nevertheless, up to now, more than 1900 COVID-19 patients have been treated with ECMO for COVID-19 around the world (5).

As previously pointed out (6), ECMO is a finite resource and during the outbreak, there are limitations to providing ECMO, such as lack of material or limited staff available, which may restrict the access of patients to ECMO.

The aim of the study is to evaluate the feasibility, efficacy and safety of interhospital transport of patients on ECMO during the COVID-19 outbreak. It is a prospective observational study that comparestransport related variables of all patients retrieved on ECMO between March 15 th and April 30 th 2020, with an historical cohort of patients transported on ECMO during the previous 6 months.

Controls were randomly selected from the institution´s ECMO patient registry, matching the number of patients included during the study period. Since ECMO patients are highly selected (age, days of mechanical ventilation, comorbidities, etc), no matching by other variables was done. The study is performed in a tertiary ECMO center in Spain that receives referrals from 9 different hospitals in a region of 2.2 million inhabitants.

During the outbreak, contact with the ECMO center was performed using a centralized telephone number and online registration form, as usually done.

Specific information about ECMO in COVID-19 patients was distributed among the network hospitals. (table 2) . During two retrievals, one of the team members had intolerance to the personal protection equipment and needed to be substituted by another team member. None of the members of the team had symptoms or were tested positive in CRP for SARS-CoV-2 during the study period.

The main finding of our study is that retrieval of COVID-19 patients on ECMO during the outbreak is feasible and safe in the setting of a previously wellestablished mobile ECMO program. To our knowledge this is the first study that directly compares interhospital transport of COVID-19 ECMO patients to a historical cohort. ECMO is a life-saving technique that might be useful for treatment of refractory respiratory failure in COVID-19 patients. Nevertheless, up to now, there are insufficient data about their outcomes. Our case series shows a similar survival rate between groups; however, the low number of patients makes data interpretation difficult. Upcoming reports from ELSO, EuroELSO and Critical Care Consortium will shed some light on this issue.

To be pointed out is that COVID-19 patients had more days of mechanical ventilation prior to the start of ECMO. We hypothesize this could be due to a slower evolution of the disease and/or an increase in super-infections due to immunomodulatory therapy used, when compared to other causes of ARDS, which may lead to refractory hypoxemia and/or hypercapnia in a posterior stage. However, late worsening of the respiratory function associated to ventilation induced lung injury is to be ruled out in COVID-19 patients aswell.

Despite the outbreak, all patients considered for ECMO could be retrieved, maintaining the standard of care established by the institution, following the recommendations for safe transport of COVID-19 patients (8). As previously pointed out, in patients under mechanical ventilation (9), the possibility of having the space, staff and stuff is a key factor for having good results in situations where the needs are close to exceed the attention capacity.

In conclusion, transport of COVID-19 patients on ECMO is feasible and safe in a regional ECMO center. More data are necessary to determine the efficacy of ECMO in COVID-19 patients. 

Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): A MULTICENTRE RANDOMISED CONTROLLED TRIAL

Position paper for the organization of extracorporeal membrane oxygenation programs for acute respiratory failure in adult patients

Clinical characteristics of coronavirus disease 2019 in China

Preparing for the most critically ill patients with COVID-19. The potential role of extracorporeal membrane oxygenation

Extracorporeal life support organization COVID-19 interim guidelines

Recomendaciones de «hacer» y «no hacer» en el tratamiento de los pacientes críticos ante la pandemia por coronavirus causante de COVID-19 de los Grupos de Trabajo de la Sociedad Española de Medicina Intensiva

Mechanical Ventilation during the coronavirus disease 2019 pandemic